Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vax-MEN-ACW135
- Development stage
- Unknown
- Lead developer
- Finlay Vaccine Institute
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
vax-MEN-ACW135 is a trivalent polysaccharide vaccine developed by the Finlay Vaccine Institute for the prevention of meningococcal disease. It is designed to provide protection against *Neisseria meningitidis* serogroups A, C, and W135. The vaccine works by introducing purified capsular polysaccharides from these specific serogroups, which act as antigens to stimulate the host's immune system to produce protective bactericidal antibodies. It is primarily indicated for active immunization in individuals at risk of infection by these serogroups and is currently approved for use in regions where these serogroups are prevalent.
- Brand names
- vax-MEN-ACW135vax-MEN-ACW-135vax-MEN-ACW 135vax-MEN-ACW®135
- Other names
- meningococcal polysaccharide vaccine (groups A, C, W135)trivalent meningococcal polysaccharide vaccine
02
Targets
NmA CPS (Neisseria meningitidis group A capsular polysaccharide)Neisseria meningitidis group C capsular polysaccharideMenW CPS (Neisseria meningitidis serogroup W capsular polysaccharide)
Beyond the preview
Go deeper on vax-MEN-ACW135.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vax-MEN-ACW135.